SynthesisBMC medicine2025
Global perspectives on the Sleep Condition Indicator for DSM-5 insomnia disorder: a COSMIN and STARD systematic review of psychometric and diagnostic performance.
Synthesis in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundA robust insomnia screening and measuring tool is essential for accurately assessing and diagnosing insomnia in research and clinical settings. The Sleep Condition Indicator (SCI) is an initial screening tool designed to assess insomnia complaints according to the DSM-5 criteria. This study aims to systematically evaluate item content, psychometric performance, diagnostic performance, and overall application of the SCI through a methodological quality assessment of original validation studies. These findings offer valuable information for optimizing insomnia diagnosis, assessment, and monitoring.
methodsA comprehensive search was conducted for finding studies published from 2012 to 2024, in PubMed, EMBASE, CINAHL, and MEDLINE electronic databases, and citation searching in PubMed, SCOPUS, Web of Science, and Google Scholar. Full-text articles focusing on the translation, validation, and application of the SCI were included. The psychometric studies were assessed regarding their measurement properties and methodological quality, using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. The diagnostic studies were assessed using the Standard for Reporting of Diagnostic Accuracy (STARD) guidelines. Finally, studies in which the SCI was used for assessment or screening purposes provided general information on the application of the scale.
resultsWe identified 285 studies with over 720,000 participants that used the SCI, and 13 language versions of the SCI were employed across at least 31 regions. The most commonly assessed measurement properties of the SCI within 19 studies were structural validity, internal consistency, criterion validity, and reliability, with findings supporting a stable two-factor structure and credible overall psychometric properties. The SCI demonstrated adequate sensitivity and specificity in 14 studies evaluating its diagnostic performance, and a cut-off value of 16 was recommended for screening insomnia. Finally, the studies showed that the SCI is widely used across clinical and non-clinical settings and provides valuable information for assessing insomnia risks.
conclusionsThe SCI includes items that align with the most current diagnostic criteria for insomnia disorder from the DSM-5. This tool demonstrates excellent psychometric performance and strong diagnostic performance. Overall, the SCI provides useful information for screening, diagnosing, and monitoring insomnia, making it a valuable tool in both research and clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.